Investor Relations

Enhancing shareholder value through exceptional business performance and practices, and through responsible and effective communication with its shareholders.

Press Releases

Read about the latest Hoth Therapeutics technology, research, investor updates and much more.

View All

Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Terms of Use.

Our Purpose

Founded in 2017, Hoth Therapeutics, Inc. was formed as a global platform to commercialize innovative and proprietary therapeutics. The company aims to launch scientifically advanced products to address unmet needs and deliver value to patients as well as all healthcare stakeholders.
Our Latest Presentation
Email Alerts

Quick Links

Board of Directors

Learn more about the members that make up our Board of Directors
Learn More

SEC Filings

View annual filings, quarterly filings and more
Learn More

FAQ’s

Check out our frequently asked questions for more information
Learn More

Events

Upcoming and past investor related events and announcements
Learn More

Our Pipeline

Focused on developing innovative
therapeutics to meet unmet needs.

Learn More About Our Science

Pipeline

Inflammatory

Devices

Dermatology

Neurology

Oncology